Free Trial

Brokerages Set Cresco Labs Inc. (OTCMKTS:CRLBF) PT at $3.00

Cresco Labs logo with Medical background

Shares of Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) have received an average rating of "Buy" from the five analysts that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $3.00.

Separately, Cormark upgraded shares of Cresco Labs from a "hold" rating to a "moderate buy" rating in a report on Monday, March 17th.

View Our Latest Research Report on Cresco Labs

Cresco Labs Price Performance

CRLBF stock traded down $0.02 during mid-day trading on Monday, reaching $0.69. The company's stock had a trading volume of 303,378 shares, compared to its average volume of 632,320. The stock has a market cap of $340.86 million, a PE ratio of -3.47 and a beta of 1.73. The company has a current ratio of 1.97, a quick ratio of 1.39 and a debt-to-equity ratio of 1.80. Cresco Labs has a fifty-two week low of $0.52 and a fifty-two week high of $2.35. The company's 50 day moving average is $0.72 and its two-hundred day moving average is $0.92.

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last posted its quarterly earnings results on Friday, March 14th. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01). The business had revenue of $176.00 million during the quarter, compared to analysts' expectations of $172.10 million. Cresco Labs had a negative net margin of 9.15% and a negative return on equity of 16.52%. Equities research analysts expect that Cresco Labs will post -0.2 EPS for the current year.

Cresco Labs Company Profile

(Get Free Report

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Featured Articles

Analyst Recommendations for Cresco Labs (OTCMKTS:CRLBF)

Should You Invest $1,000 in Cresco Labs Right Now?

Before you consider Cresco Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.

While Cresco Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines